Paige has developed powerful AI applications to support diagnostic decision making in cancer pathology. In addition, Paige’s novel AI technologies can reveal multiple molecular biomarkers directly from the tissue sample. Developed to assist the diagnostic workflow in pathology, Paige’s AI applications can alleviate time and resource pressures enabling pathologists to better balance their ever-growing workloads while still delivering informed, quality diagnoses.
The Paige Prostate Suite is a group of comprehensive AI-powered applications that aid in the detection and grading of prostate cancer on H&E-stained whole-slide images of prostate needle biopsies. Paige Prostate is CE approved and was the first AI-based software application in pathology to receive FDA approval to aid in the primary diagnosis of prostate cancer.
Independent validation studies have shown Paige Prostate Detect to
Access publications here: https://www.paige.ai/publications
The Paige Breast Suite is a set of AI-powered applications that support in the identification and classification of breast cancer on H&E-stained whole-slide images from breast biopsy and excision specimens.
Paige Breast Detect & Neoplasm: Highlights foci suspicious for cancer and pre-cancerous neoplasms
Paige Breast Mitosis: Identifies individual mitotic figures, locates the mitotic hotspot, and automatically calculates mitotic counts mitotic density
Paige Breast Lymph Node: Detects foci that are suspicious for breast cancer metastasis from lymph node specimens
HER2Complete: AI assay that can measure HER2 expression from H&E samples, including the identification of HER-2 low patients
Studies have shown that Paige Breast Lymph Node AI can detect metastases of any size with 98% sensitivity and shorten the reading time of lymph node slides by as much as 55%: https://www.paige.ai/publications
The Paige GI Suite is a new and powerful portfolio of AI-powered applications designed to support pathologists in the detection and classification of benign and malignant condition across the entire gastrointestinal tract.
Paige GI Detect & Subtype: Detect, classify and localize cancer, pre-cancer and benign lesions in biopsies and resection specimens from anywhere across the GI systems including esophagus, stomach, small intestine, gall bladder, pancreas, large bowel and rectum
Paige Colon Detect: Identifies foci suspicious for colon carcinoma and high-grade dysplasia (HGD)
Paige Colon MSI: Detects the presence or absence of high microsatellite instability (MSI-H) or mismatch repair-deficient (dMMR) phenotypes from colon biopsies and resections containing cancer
Paige PanCancer Detect⁺ is the first AI application of its kind designed to identify regions suspicious for cancer across multiple tissues and organs. Built to detect regions of interest that might have otherwise been missed, Paige PanCancer can empower pathologists to triage cases more efficiently.
Paige PanCancer was awarded FDA Breakthrough Device Designation, this application has been internally validated on 21 biopsy and 25 resection tissue types, making it a uniquely flexible tool to analyze a range of diverse cases. While tested on these tissues, PanCancer’s capabilities could extend even further.
Traditional molecular testing can be costly, time-consuming, and require a lot of tissue. Paige OmniScreen⁺™ offers a next-generation AI-driven approach to pre-screening for clinically relevant biomarkers, providing a faster, more cost-effective, and tissue-sparing alternative to traditional molecular testing. By bridging the gap between pathology and genomics, OmniScreen enables study participant selection, more efficient testing strategies, and streamlined decision-making across clinical and research settings.
Accelerate Biomarker Discovery & Research
Expedite Patient Enrollment
Reduce Costs & Conserve Tissue
Omniscreen is for research use only
Cancer diagnosis is complex, but with Paige, it’s never been more precise.
Our AI-powered solutions provide a deep understanding of cancer’s molecular and cellular complexities, helping to deliver reliable detection and characterization of disease. From tissue analysis to molecular profiling, we’re redefining what’s possible in precision diagnostics.
To truly understand cancer, you need to start at its foundation—pathology. Paige’s groundbreaking approach begins here, combining advanced AI expertise with insights from world-renowned medical and scientific experts. Leveraging the largest, most diverse digital pathology dataset available, our technology delivers novel insights like never before.
Paige’s exclusive access to millions of digitized pathology slides, clinical reports, and genomic data sets us apart. By leveraging this data, we bring an enhanced understanding of cancer to patients, helping drive transformative breakthroughs in cancer diagnostics and care.
Digital Pathology 
+45 60 14 18 84
fba@humanbytes.ai